General
AstraZeneca denies reports its COVID-19 vaccine has low efficacy in elderly people
Pharmaceutical company AstraZeneca has denied media reports that its COVID-19 vaccine is not very effective for people over 65.
Key points:
- AstraZeneca said media reports about the vaccine’s efficacy in the elderly were “completely incorrect”
- The company said strong immune responses had been shown in blood analysis of elderly trial participants
- The Oxford/AstraZeneca vaccine has not yet been approved in Australia
In separate reports, German daily papers Handelsblatt and Bild said the vaccine had an efficacy of 8 per cent or less than 10 per cent, respectively, in people over 65 years of age.
German officials were concerned the vaccine may not receive approval from the European Union’s European Medicines Agency for use in those over 65, Bild…
Continue Reading
-
General21 hours agoGiorgio Armani farewelled by large crowds of mourners in Milan
-
Noosa News15 hours agoBruce and Denise Morcombe discuss Daniel’s Law
-
General15 hours agoChina, Russia, North Korea and Iran’s ‘axis of upheaval’ reshapes geopolitics
-
Business14 hours agoWhy these are 2 of the most exciting ASX 300 shares to buy right now